Symbiotec Pharmalab Limited (NSE:SYMBIOTEC)
India · Delayed Price · Currency is INR 1,198.00
+21.25 (1.81%)
At close: Oct 1, 2026
Symbiotec Pharmalab Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Assets
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | - | 100.4 | 263.9 | 74.95 | 45.51 | 91.62 |
Short-Term Investments | - | 0.85 | 0.79 | 0.68 | 8.73 | 3.79 |
Cash & Short-Term Investments | 101.25 | 101.25 | 264.69 | 75.63 | 54.24 | 95.41 |
Cash Growth | - | -61.75% | 249.98% | 39.44% | -43.15% | - |
Accounts Receivable | - | 2,001 | 1,757 | 1,257 | 1,120 | 1,435 |
Other Receivables | - | 114.64 | 158.59 | 140.16 | 139.84 | 58.04 |
Receivables | - | 2,116 | 1,915 | 1,397 | 1,259 | 1,493 |
Inventory | - | 2,369 | 2,615 | 3,358 | 2,438 | 2,457 |
Prepaid Expenses | - | 52.92 | 50.74 | 50.95 | 44.59 | 57.26 |
Other Current Assets | - | 216.84 | 83.49 | 200.76 | 205.74 | 152.27 |
Total Current Assets | - | 4,855 | 4,929 | 5,082 | 4,002 | 4,255 |
Property, Plant & Equipment | - | 11,489 | 9,697 | 6,195 | 4,807 | 3,184 |
Long-Term Investments | - | 44.84 | 14.5 | 35.11 | 48.19 | 54.05 |
Other Intangible Assets | - | - | - | 2.38 | 7.5 | 12.62 |
Other Long-Term Assets | - | 1,419 | 1,156 | 1,633 | 1,036 | 646.3 |
Total Assets | - | 17,808 | 15,797 | 12,948 | 9,900 | 8,152 |
Liabilities
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Accounts Payable | - | 1,383 | 884.96 | 2,276 | 879.7 | 887.73 |
Accrued Expenses | - | 196.22 | 147.1 | 129.51 | 124.43 | 167.7 |
Short-Term Debt | - | 2,875 | 2,284 | 502.97 | 1,053 | 635.88 |
Current Portion of Long-Term Debt | - | 319.99 | 595.04 | 16.66 | 6 | 3.36 |
Current Portion of Leases | - | 10.25 | 8.77 | 5.47 | - | - |
Current Income Taxes Payable | - | 79.46 | 110.08 | 30.49 | 4.88 | 20.34 |
Current Unearned Revenue | - | 135.05 | 358.15 | 417.21 | 71.1 | 53.96 |
Other Current Liabilities | - | 276.39 | 337.8 | 133.68 | 141.84 | 118.01 |
Total Current Liabilities | - | 5,276 | 4,726 | 3,512 | 2,281 | 1,887 |
Long-Term Debt | - | 684.13 | 2,530 | 1,952 | 1,120 | 7.31 |
Long-Term Leases | - | 20.51 | 26.42 | 28.44 | 20.78 | 11.32 |
Long-Term Unearned Revenue | - | 39.58 | - | - | - | - |
Pension & Post-Retirement Benefits | - | 168.83 | 94 | 77.3 | 60.92 | 55.76 |
Long-Term Deferred Tax Liabilities | - | 58.13 | 219.91 | 199.44 | 201.58 | 204.47 |
Other Long-Term Liabilities | - | 65.19 | 53.04 | 29.72 | 1.47 | - |
Total Liabilities | - | 6,312 | 7,649 | 5,799 | 3,685 | 2,166 |
Shareholders' Equity
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Common Stock | - | 125.47 | 109.36 | 109.36 | 109.36 | 109.36 |
Additional Paid-In Capital | - | 3,910 | 1,611 | 1,611 | 1,611 | 1,611 |
Retained Earnings | - | 7,542 | 6,446 | 5,484 | 4,495 | 4,266 |
Comprehensive Income & Other | - | -80.82 | -17.76 | -54.22 | - | - |
Total Common Equity | 11,497 | 11,497 | 8,149 | 7,150 | 6,215 | 5,987 |
Minority Interest | - | -1.4 | -1.89 | -2.05 | -0.92 | -1.09 |
Shareholders' Equity | 11,496 | 11,496 | 8,147 | 7,148 | 6,214 | 5,986 |
Total Liabilities & Equity | - | 17,808 | 15,797 | 12,948 | 9,900 | 8,152 |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Total Debt | 3,910 | 3,910 | 5,444 | 2,506 | 2,200 | 657.87 |
Net Cash (Debt) | -3,809 | -3,809 | -5,180 | -2,430 | -2,145 | -562.46 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -60.71 | -65.86 | -92.89 | -43.66 | -39.23 | -10.29 |
Filing Date Shares Outstanding | 62.73 | 62.73 | 54.68 | 55.66 | 54.68 | 54.68 |
Total Common Shares Outstanding | 62.73 | 62.73 | 54.68 | 55.66 | 54.68 | 54.68 |
Working Capital | - | -420.21 | 202.6 | 1,570 | 1,721 | 2,368 |
Book Value Per Share | 183.27 | 183.27 | 149.02 | 128.46 | 113.66 | 109.49 |
Tangible Book Value | 11,497 | 11,497 | 8,149 | 7,148 | 6,208 | 5,974 |
Tangible Book Value Per Share | 183.27 | 183.27 | 149.02 | 128.42 | 113.53 | 109.26 |
Land | - | 103.55 | 102.01 | 101.01 | 101.01 | 101.01 |
Buildings | - | 2,809 | 1,308 | 1,268 | 979.51 | 924.58 |
Machinery | - | 10,434 | 4,605 | 4,331 | 3,131 | 2,915 |
Construction In Progress | - | 644.81 | 5,682 | 2,083 | 1,821 | 396.79 |